Candidiasis Clinical Trials

24 recruitingLast updated: June 18, 2026

There are 24 actively recruiting candidiasis clinical trials across 30 countries. Studies span Not Applicable, Phase 2, Phase 3, Early Phase 1. Top locations include Houston, Texas, United States, Bethesda, Maryland, United States, Birmingham, Alabama, United States. Updated daily from ClinicalTrials.gov.


Candidiasis Trials at a Glance

24 actively recruiting trials for candidiasis are listed on ClinicalTrialsFinder across 6 cities in 30 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Houston, Bethesda, and Birmingham. Lead sponsors running candidiasis studies include National Institute of Allergy and Infectious Diseases (NIAID), Basilea Pharmaceutica, and Arkansas Children's Hospital Research Institute.

Browse candidiasis trials by phase

Treatments under study

About Candidiasis Clinical Trials

Looking for clinical trials for Candidiasis? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Candidiasis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Candidiasis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 24 trials

Recruiting
Phase 3

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

CandidemiaCandidiasis, Invasive
Basilea Pharmaceutica450 enrolled143 locationsNCT05421858
Recruiting
Phase 2

Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence

Candidiasis, Vulvovaginal
Sano Chemicals Inc36 enrolled1 locationNCT07521137
Recruiting

Natural History of Individuals With Immune System Problems That Lead to Fungal Infections

Invasive AspergillosisAPECEDChronic Mucocutaneous Candidiasis+1 more
National Institute of Allergy and Infectious Diseases (NIAID)1,200 enrolled1 locationNCT01386437
Recruiting
Phase 3

Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis

Vulvovaginal Candidiasis (VVC)Vulvovaginal CandidiasesVulvovaginal Candidiasis, Genital
pH-D Feminine Health LLC400 enrolled27 locationsNCT07109869
Recruiting
Not Applicable

Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for Vulvovaginal Candidiasis

Vulvovaginal Candidiasis (VVC)
Bioithas SL60 enrolled1 locationNCT07603895
Recruiting
Not Applicable

Comparison of Uncomplicated Candidemia Therapy Duration in Children

Invasive Candidiasis
Arkansas Children's Hospital Research Institute420 enrolled22 locationsNCT05763251
Recruiting
Not Applicable

An Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Vulvovaginal Candidiasis Compared With an Untreated Control Group

Vulvovaginal Candidiasis (VVC)
Gedea Biotech AB48 enrolled3 locationsNCT07405853
Recruiting
Early Phase 1

Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome

Vulvovaginal candidiasisBacterial vaginosis
Queen's Medical Center22 enrolled1 locationNCT05753813
Recruiting
Not Applicable

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

Vulvovaginal Candidiasis (VVC)Yeast Vaginitis
Coologics, Inc55 enrolled10 locationsNCT06983041
Recruiting
Phase 2

Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis
National Institute of Allergy and Infectious Diseases (NIAID)10 enrolled1 locationNCT07202598
Recruiting
Not Applicable

PTX3-targeted Antifungal Prophylaxis

Acute Myeloid LeukemiaGenetic PredispositionCandidiasis+2 more
Bochud Pierre-Yves410 enrolled9 locationsNCT03828773
Recruiting
Phase 2

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

Alopecia AreataAutoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)
National Institute of Allergy and Infectious Diseases (NIAID)70 enrolled1 locationNCT05398809
Recruiting
Not Applicable

Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal Infections

Bacterial vaginosisVaginal Candidiasis
Karo Pharma AB80 enrolled1 locationNCT07234786
Recruiting

Invasive Candidiasis in Critical Care

Invasive Candidiasis
University Hospital Ostrava100 enrolled2 locationsNCT06456151
Recruiting
Phase 2Phase 3

Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis

Candidal Vulvovaginitis (ICD-10 Code: B37.3)Vulvovaginal Candidiasis (VVC)
AVVA Pharmaceuticals Ltd.264 enrolled7 locationsNCT06835361
Recruiting
Phase 2

A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis

Patients With Candidemia and/or Invasive Candidiasis
Fujian Shengdi Pharmaceutical Co., Ltd.40 enrolled1 locationNCT06194201
Recruiting
Not Applicable

Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis

Vulvovaginal candidiasis
The Archer-Daniels-Midland Company126 enrolled6 locationsNCT06480604
Recruiting

Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes

Vulvovaginal candidiasisVaginal CandidiasisCandida Infection
Scynexis, Inc.100 enrolled1 locationNCT05908682
Recruiting
Phase 2Phase 3

Postbiotic as Adjunct Treatment for Vaginal Candidiasis

Vaginal Candidiasis
Min-Tze LIONG118 enrolled2 locationsNCT06474247
Recruiting
Not Applicable

Early Discontinuation of Empirical Antifungal Therapy and Biomarkers

Invasive Candidiasis
University Hospital, Lille194 enrolled10 locationsNCT03538912